**Summary:**
This circular, reference number A32029012020D, issued by the Ministry of Health and Family Welfare, Central Drugs Standard Control Organization (CDSCO), HQ Admin. Section, FDA Bhawan, New Delhi, dated April 7, 2021, pertains to RT-PCR testing for COVID-19 of CDSCO HQ staff at FDA Bhawan. The circular references previous communications, specifically letter number T-12015/4/2020-H dated 07.04.2020 and office memorandum number Z.28015/119/2020-H dated 19.03.2021. Section Officer T. Baite, CDSCO HQ, is the contact person. The circular is addressed to all officers and officials (regular and contractual) of CDSCO HQ. Copies are distributed to all officers/officials, the IT Cell (for website upload), and the DCGI Secretariat, CDSCO HQ.
Key Entities Referenced
Ministry of Health and Family Welfare: The Indian government ministry responsible for health policy in India.
Central Drugs Standard Control Organization: The national regulatory body for pharmaceuticals and medical devices in India.
CDSCOHQ: Refers to the headquarters of the Central Drugs Standard Control Organization.
FDA Bhawan, New Delhi: The location of the CDSCO headquarters in New Delhi, Delhi.
BRT h aP wC aR n ,T e Nst e wfo r D eC lo hiv i d l e1 g9: Subject of the circular is regarding Testing for Covid 19
IG: Appears to refer to an Inspection General or similar role within the CDSCO.
DCGI Secretariat, CDSCOHQ: The office of the Drugs Controller General of India within the CDSCO headquarters.
IT Cell, CDSCO: The Information Technology cell of the Central Drugs Standard Control Organization responsible for the CDSCO's website.